BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21761028)

  • 1. Warthin's tumour mimicking nodal involvement by thyroid cancer and unexplained elevation of serum thyroglobulin.
    Loo SW; Lu SJ; Geropantas K; Martin C; Roques TW
    Hell J Nucl Med; 2011; 14(2):184-5. PubMed ID: 21761028
    [No Abstract]   [Full Text] [Related]  

  • 2. Mucoepidermoid carcinoma arising in Warthin's tumor: a case report.
    Mardi K; Sharma J
    Indian J Pathol Microbiol; 2007 Apr; 50(2):331-3. PubMed ID: 17883061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thyroglobulin RT-PCR method for detection of lymph node metastases during the course of differentiated thyroid cancers].
    Gubała E; Handkiewicz-Junak D; Zeman M; Chmielik E; Wiench M; Jarzab B
    Wiad Lek; 2001; 54 Suppl 1():349-56. PubMed ID: 12182047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral intraparotid and extraparotid Warthin's tumours.
    Shah N; Tighe JV; Barrett AW; Kumar S; Allen JP
    Br J Oral Maxillofac Surg; 2007 Apr; 45(3):238-9. PubMed ID: 16207506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary thyroid carcinoma in a 3-year-old child: case report.
    Alkan S; Seven H; Sakalli E; Dadaş B
    Int J Pediatr Otorhinolaryngol; 2008 Feb; 72(2):275-7. PubMed ID: 18061281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thyroglobulin levels in needle lymph node cytology for the detection of papillary thyroid cancer recurrence].
    Véliz J; Brantes S; Ramos C; Aguayo J; Cáceres E; Herrera M; Barber A; Barría M; Wohllk N
    Rev Med Chil; 2008 Sep; 136(9):1107-12. PubMed ID: 19030653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
    Lind P; Igerc I; Kohlfürst S
    Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periparotid multifocal Warthin's tumour.
    Alwan MH; Kirkwood S
    ANZ J Surg; 2011 Mar; 81(3):183-4. PubMed ID: 21342394
    [No Abstract]   [Full Text] [Related]  

  • 9. Level IIb lymph node metastasis in neck dissection for papillary thyroid carcinoma.
    Lee BJ; Wang SG; Lee JC; Son SM; Kim IJ; Kim YK
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1028-30. PubMed ID: 17938327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant oncocytoma of major salivary glands. Report of a post-irradiation case.
    Coli A; Bigotti G; Bartolazzi A
    J Exp Clin Cancer Res; 1998 Mar; 17(1):65-70. PubMed ID: 9646235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of distribution of nodal disease in differentiated thyroid cancers in an oncosurgical center in Sri Lanka.
    Amarasinghe IY; Perera NM; Bahinathan N; Marzook HH; Peiris AK
    Ann Surg Oncol; 2007 May; 14(5):1560-4. PubMed ID: 17318279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undifferentiated thyroglobulin-positive thyroid cancer 45 years after treatment for papillary primary.
    Reu F; Srkalovic G
    Clin Adv Hematol Oncol; 2003 Apr; 1(4):242; discussion 243. PubMed ID: 16224416
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of lymph nodal impairment of differentiated thyroid cancer on prognosis.
    De Andrade RP
    Rev Paul Med; 1993; 111(4):46-8. PubMed ID: 8108648
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroglobulin monitoring after treatment of well-differentiated thyroid cancer.
    Hamy A; Mirallié E; Bennouna J; Resche I; Drefty C; Johnstone M; Visset J
    Eur J Surg Oncol; 2004 Aug; 30(6):681-5. PubMed ID: 15256244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
    Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
    J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment.
    Bachelot A; Leboulleux S; Baudin E; Hartl DM; Caillou B; Travagli JP; Schlumberger M
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):376-9. PubMed ID: 15730423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insular carcinoma of the thyroid. Apropos of a case and review of the literature].
    Auge B; Rodier JF; Pusel J; Janser JC
    Arch Anat Cytol Pathol; 1993; 41(3-4):124-8. PubMed ID: 8279853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of detecting thyroglobulin in fine-needle aspirates from patients with neck lesions using a sensitive thyroglobulin assay.
    Sigstad E; Heilo A; Paus E; Holgersen K; Grøholt KK; Jørgensen LH; Bogsrud TV; Berner A; Bjøro T
    Diagn Cytopathol; 2007 Dec; 35(12):761-7. PubMed ID: 18008339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative serum thyroglobulin and neck ultrasound to drive decisions about iodine-131 therapy in patients with differentiated thyroid carcinoma: an evidence-based strategy?
    Giovanella L; Avram AM; Clerc J; Hindié E; Taïeb D; Verburg FA
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2155-2158. PubMed ID: 30062605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.